Stay updated on Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The record presents details of a Phase 2 study of sacituzumab govitecan for metastatic castration-resistant prostate cancer, including its treatment plan, eligibility criteria, outcome measures, and study locations. It also includes the study’s current status and record history.
    Difference
    50%
    Check dated 2026-10-17T15:14:41.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer displays site revision v3.7.1 instead of v3.7.0. The study page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T15:16:08.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the usual study content and navigation. This makes the trial record inaccessible and blocks users from viewing the study details.
    Difference
    18%
    Check dated 2026-09-19T20:25:55.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added metadata entries: Prostate cancer; related topics: MedlinePlus Genetics. These additions connect the study to disease-focused and genetics-related indexing, improving discoverability for users exploring prostate cancer and genetics resources.
    Difference
    0.2%
    Check dated 2026-09-12T18:15:28.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, a minor update to the page's version metadata. No study content or results were changed.
    Difference
    0.1%
    Check dated 2026-08-29T21:59:58.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5, indicating a newer build of the page. It likely includes bug fixes or small improvements without changing the study information displayed.
    Difference
    0.1%
    Check dated 2026-08-08T20:52:27.000Z thumbnail image

Stay in the know with updates to Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in mCRPC after 2nd Gen AR Clinical Trial page.